ALKERMES | Aktywa



Assets Zmiana Data
AbbVie USD 135.16B 8.26B 2024-12
Acadia Pharmaceuticals USD 1.13B 55.39M 2025-03
ALKERMES USD 2.08B 26.41M 2025-03
Amgen USD 89.37B 2.47B 2025-03
Biogen USD 28.03B 16.2M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
J&J USD 193.67B 13.57B 2025-03
Malin Corporation EUR 128.4M 11.8M 2024-06
Merck USD 115.12B 1.98B 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Otsuka Holdings JPY 3.69T 46.2B 2025-03
Pfizer USD 208.03B 5.37B 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



ALKERMES Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.